Given that inflammatory markers are dysregulated in PD and diabetes, levels of TNF, IFNy and myeloid dendritic cells could be potential diagnostic biomarkers for PD (Ciaramella et al., 2013; Eidson et al., 2017). This evidence concerns the gene TNF and Parkinson disease.